Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corp (SRRK) from its SEC filings: 2025 revenue $0 (-100% vs the year before), free cash flow -$300.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Revenue (2025) | $0 |
| Revenue growth | -100% |
| Net income | -$378.0 million |
| Free cash flow | -$300.6 million |
| Diluted EPS | $-3.29 |
| Cash | $437.1 million |
| Long-term debt | $196.2 million |
| Share count, 1 year | +27% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.